Union Korea Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '24 Oct 10, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	19,700	15,410	35,741	51,626	78,193	145,429
Market Cap Growth	-45.97%	-56.88%	-30.77%	-33.98%	-46.23%	77.22%
Enterprise Value	51,099	36,636	69,920	79,902	92,488	152,610
Last Close Price	2725.00	2725.00	4950.00	7150.00	10150.00	18400.00
PS Ratio	0.58	0.30	0.57	0.84	1.62	2.89
PB Ratio	-2.08	1.87	1.18	1.06	1.46	2.13
P/TBV Ratio	-	2.05	1.22	1.10	1.55	2.19
P/OCF Ratio	50.58	37.11	26.24	-	40.84	-
EV/Sales Ratio	1.51	0.71	1.11	1.30	1.92	3.03
EV/EBITDA Ratio	-	-	-	15.18	-	-
EV/EBIT Ratio	-	-	-	62.84	-	-
Debt / Equity Ratio	-2.41	2.91	1.30	0.76	0.67	0.22
Debt / EBITDA Ratio	-	-	-	7.05	-	-
Debt / FCF Ratio	127.24	-	-	-	-	-
Net Debt / Equity Ratio	-2.03	2.21	1.06	0.61	0.28	0.18
Net Debt / EBITDA Ratio	-0.74	-1.16	-2.98	5.62	-2.31	-1.72
Net Debt / FCF Ratio	107.42	-34.13	-35.70	-3.51	-2.81	-1.21
Asset Turnover	0.48	0.61	0.61	0.53	0.45	0.52
Inventory Turnover	3.39	3.57	4.11	3.18	2.72	2.53
Quick Ratio	0.32	0.42	0.70	0.70	1.11	1.28
Current Ratio	0.46	0.63	0.84	0.93	1.36	1.91
Return on Equity (ROE)	-477.51%	-108.22%	-46.00%	-1.82%	-18.22%	-14.75%
Return on Assets (ROA)	-24.50%	-13.74%	-8.87%	0.69%	-6.14%	-6.99%
Return on Invested Capital (ROIC)	-184.15%	-41.83%	-20.87%	-1.71%	-14.26%	-13.57%
Return on Capital Employed (ROCE)	-242.90%	-169.90%	-41.50%	2.40%	-14.00%	-14.60%
Earnings Yield	-154.40%	-135.44%	-50.80%	-1.80%	-14.21%	-6.41%
FCF Yield	0.91%	-3.47%	-2.52%	-16.33%	-6.72%	-6.90%
Buyback Yield / Dilution	-5.94%	-0.10%	2.14%	5.05%	-16.95%	-12.55%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.